Browse Guides  internal medicine  neurology

Stroke

Prevalence
Clinical features
Investigations
Therapy
Prevention
Prognosis
Therapy

There is no clear benefit from fibrinogen-depleting agents d

Why?

  • Fibrinogen-depleting agents have no clear effect on reducing death or disability following an acute ischaemic stroke or an intracranial haemorrhage d

Expiry date: October 2003
Levels of Evidence used in grading these guides

Author   CM   Ball
Reviewer   G  Donnan
CAT Writers   CJ   Wotton , N   Shenker , CM   Ball